3 disclosed rounds · sourced from the FOBI roster
| Date | Stage | Amount | Valuation | Lead investors |
|---|---|---|---|---|
| 2021-06-09 | Growth | — | $7B | Sixth Street, Goldman Sachs Asset Management, New Mountain Capital, Roivant Sciences, Transformation Capital, Merck Global Health Innovation Fund, Labcorp, Cigna Ventures, Johnson & Johnson Innovation – JJDC, Inc., Flex Capital |
| 2020-10-08 | Series B | $40M | — | Transformation Capital |
| 2018-04-30 | Series A | $40.5M | — | Roivant Sciences, Travis May |